22 results
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Vasculitis Management ... - ACR/VF 2021 Guidelines ... for Treatment & ... #Management #Treatment ... #algorithm #rheumatology
Treatment Algorithm for Pulmonary Hypertension

#Pulmonary #Hypertension #PAH #Treatment #Management #Algorithm #Medications
Treatment Algorithm ... for Pulmonary Hypertension ... #Pulmonary # ... #Management #Algorithm ... #Medications
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
Nodosa (PAN) - Vasculitis ... Management Algorithm ... - ACR/VF 2021 Guidelines ... #Management #Treatment ... #ACR2021 #Guidelines
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Management Algorithm ... - ACR/VF 2021 Guidelines ... #Management #Treatment ... #ACR2021 #Guidelines ... #algorithm #rheumatology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
(EGPA) - ANCA Vasculitis ... Management Algorithm ... - ACR/VF 2021 Guidelines ... #Management #Treatment ... #ACR2021 #Guidelines
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Arteritis (GCA) - Vasculitis ... Management Algorithm ... - ACR/VF 2021 Guidelines ... #Management #Treatment ... #ACR2021 #Guidelines
Massive Hemoptysis - Differential Diagnosis Framework and Management
Definition: 150-600 mL over 24 hours
Differential Diagnosis:
 • Tracheobronchial:
Massive Hemoptysis - Differential ... Primary Vascular: Pulmonary ... Embolism, Vasculitis ... : 1) Indications ... #pulmonary #criticalcare
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... #GINA #Asthma #Management ... #Stepwise #Pulmonary ... #StepUp #Treatment ... #Algorithm #Guidelines
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
Management of interstitial ... Symptomatic treatment ... systemicsclerosis #SSc #pulmonary ... #indications #management ... #treatment #algorithm
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
Shock - Differential ... Failure, Toxins/Medications ... • Obstructive: Pulmonary ... #criticalcare #algorithm ... #treatment #management